Skip to main content

Cocrystal Pharma, Inc.

COCP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001412486

In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.

Superinvestors holding COCP, Q2 2026

See all superinvestors

No superinvestor reported holding COCP in Q2 2026.